Cardiff Oncology, Inc. (CRDF)
Data as of , from SEC Form 4 filings.
See up to 3 months of CRDF. The 7-day demo opens the 1M and 3M ranges and puts CRDF on your watchlist.
Start 7-day demoLatest CRDF insider trades
Gary W. PaceOpen-market purchase$1.00M- Gary W. PaceOpen-market purchase687,285 sh
About Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. files with the SEC under CIK 0001213037 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
CRDF Form 4 activity by transaction type, last 90 days
No Form 4 activity for CRDF in the last 90 days.
CRDF insider transactions (Form 4)
3226 Form 4 filings on record, the earliest from Dec 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gary W. Pace | Open-market purchase | Common Stock | 687,285 | $1.46 | $1.00M | |
| Gary W. Pace | Open-market purchase | Common Stock Purchase Warrant | 687,285 | $0.00 | - | |
| Mani Mohindru - Officer | Open-market purchase | Common Stock | 34,364 | $1.46 | $50K | |
| Mani Mohindru - Officer | Open-market purchase | Common Stock Purchase Warrant | 34,364 | $0.00 | - | |
| Mani Mohindru - Officer | Open-market purchase | Common Stock | 24,703 | $1.21 | $30K | |
| Gary W. Pace | Open-market purchase | Common Stock | 30,000 | $1.22 | $37K | |
| James O. Armitage | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Lale White | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Renee P. Tannenbaum | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Gary W. Pace | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Rodney S. Markin | Grant or award | Stock Options | 40,565 | $0.00 | - | |
 Ajay Aggarwal - Officer | Grant or award | Stock Options | 400,000 | $0.00 | - | |
 Joshua B. Muntner - Officer | Grant or award | Stock Options | 486,650 | $0.00 | - | |
| Tod Smeal - Officer | Grant or award | Stock Options | 300,000 | $0.00 | - | |
| Joshua B. Muntner - Officer | Grant or award | Stock Options | 486,650 | $0.00 | - | |
| Mani Mohindru - Officer | Grant or award | Stock Options | 600,000 | $0.00 | - | |
| Brigitte Ute Lindsay - Officer | Grant or award | Stock Options | 200,000 | $0.00 | - | |
| Mani Mohindru - Officer | Grant or award | Stock Options | 200,000 | $0.00 | - | |
| Gary W. Pace | Open-market purchase | Common Stock | 275,000 | $2.45 | $674K | |
| Gary W. Pace | Open-market purchase | Common Stock | 15,000 | $2.45 | $37K | |
| Renee P. Tannenbaum - Director | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Mani Mohindru - Director | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Rodney S. Markin - Director | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| James O. Armitage - Director | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Lale White - Director | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| Gary W. Pace - Director | Grant or award | Stock Options | 40,565 | $0.00 | - | |
| James E. Levine - Officer | Open-market purchase | Common Stock | 2,564 | $3.83 | $10K | |
| James E. Levine - Officer | Open-market purchase | Common Stock | 2,752 | $5.42 | $15K | |
| James E. Levine - Officer | Open-market purchase | Common Stock | 2,400 | $5.00 | $12K | |
| Renee P. Tannenbaum | Open-market purchase | Common Stock | 10,000 | $3.42 | $34K | |
| Gary W. Pace | Open-market purchase | Common Stock | 350,115 | $2.60 | $910K | |
| Gary W. Pace | Open-market purchase | Common Stock | 11,500 | $2.60 | $30K |
CRDF insider trading FAQ
What is the latest insider trade for CRDF?
Cardiff Oncology, Inc. (CRDF) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-16. The full record for CRDF runs to 26 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CRDF stock?
No insider purchases of CRDF were filed in the last 90 days. 14 purchases are on record for this company.
How many insiders are selling CRDF stock?
No insider sales of CRDF were filed in the last 90 days.
Where can I see CRDF SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CRDF Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gary W. Pace view on EDGAR
- - Mani Mohindru view on EDGAR
- - Mani Mohindru view on EDGAR
- - Gary W. Pace view on EDGAR
- - James O. Armitage view on EDGAR
- - Lale White view on EDGAR
- - Renee P. Tannenbaum view on EDGAR
- - Gary W. Pace view on EDGAR
- - Rodney S. Markin view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CRDF's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CRDF with a 7-day demo
- CRDF on your watchlist
- Every CRDF Form 4 filing on record
- Up to 3 months of CRDF price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
